A Study of Fruquintinib Plus Chemotherapy for Postoperative Treatment of HER2-Negative Gastric Cancer With Poor TRG
Clinical trial NCT06774222 · RECRUITING
Trial details
- NCT number
- NCT06774222
- Sponsor
- Henan Cancer Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-12
- Primary completion
- 2025-12-31
- Enrollment
- 69
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.